Pharma 10 2017 ranking

2017
2016
Name
Country
2017
2016
2017
2016
1 4 Roche Switzerland $6,089M $3,892M AA AA+
2 1 Pfizer United States $4,841M $4,401M AA+ AA+
3 2 Bayer Germany $4,654M $4,365M AA+ AAA-
4 3 Novartis Switzerland $4,055M $4,096M AA AA
5 5 Merck United States $3,413M $2,901M AA AA
6 8 Celgene United States $3,327M $2,642M AA- AA-
7 7 Sanofi France $3,213M $2,704M AA- AA-
8 6 Glaxosmithkline United Kingdom $3,210M $2,781M AA AA
9 Abbvie United States $2,599M $0M AA-
10 10 Biogen United States $2,573M $2,345M AA- AA
Loading...